AptarGroup, Inc. Appoints Matthew L. Trerotola to Its Board of Directors
September 13, 2022 at 02:30 am IST
Share
AptarGroup, Inc. announced that Matt Trerotola has joined its Board of Directors. Matt has served as the President and Chief Executive Officer for Enovis Corporation. As a highly accomplished leader with over 30 years of
experience, he has a distinct focus on accelerating organic growth as well as strategic acquisitions, margin and profitability improvements and talent development. Prior to his CEO role at Enovis, Matt was the Executive Vice President of DuPont's Safety & Protection and Electronics & Communications segment with $6.3 billion in revenue. At DuPont, he also held the overall responsibility for Advanced Materials corporate strategy and for the Asia region. In his previous roles, Matt served as DuPont's Senior Vice President, Safety & Protection and the Vice President and Group Executive for Danaher Corporation's Life Sciences division. Additionally, Matt has an extensive background in emerging markets, change management and digital strategy furthered by his roles at Videojet, Digital Ventures and McKinsey & Company. Matt holds an MBA from Harvard Business School and a Bachelor's of Science in Chemical Engineering from the University of Virginia. He also serves on the Board of Directors for Enovis Corporation.
AptarGroup, Inc. is engaged in designing and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The Company serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. The Company operates through three segments: Aptar Pharma, Aptar Beauty and Aptar Closures. Aptar Pharma segment supplies nasal drug delivery spray pumps and metered dose inhaler valves (MDIs) to the pharmaceutical and healthcare markets worldwide and supplies elastomer for injectable primary packaging components worldwide. The segment also provides services designed to accelerate and de-risk the development and regulatory approvals of drugs using drug delivery devices. The Aptar Beauty segment sells a variety of pumps, airless systems and valves to the fragrance, color cosmetics, facial skincare, personal care and home care markets. Aptar Closures segment primarily sells dispensing closures.